Jinn  Wu net worth and biography

Jinn Wu Biography and Net Worth

Director of Athenex

Jinn Wu is the Founder and President of XenoBiotic Laboratories, Inc. (XBL) in Plainsboro, New Jersey, and XBL- China in Nanjing, China. Both are contract research organizations that provide an extensive array of clinical and preclinical research services to the life sciences, biotechnology and pharmaceutical industries. Jinn earned a PhD in Natural Products and Medicinal Chemistry from the College of Pharmacy, The Ohio State University, and spent 7 years as a research leader at FMC Corporation in Princeton, NJ, and made numerous contributions in new products research and development before starting XBL. He has extensive knowledge and experience in new drug and product R&D. He is an Adjunct Professor at the University of Medicine and Dentistry of New Jersey (UMDNJ at Rutgers) since 2006, was a member of the Advisory Committee for Dean’s Council and is a member of the College of Pharmacy, The Ohio State University (2007-2013). He is also an Adjunct Professor at The Hong Kong Polytechnic University (2015 – present). He holds professional membership of the American Association of Pharmaceutical Scientists (AAPS), the International Society for the Study of Xenobiotics (ISSX), the American Society of Pharmacognosy (ASP) and the American Chemical Society (ACS). He has served as Chief Scientific Officer and Strategic Scientific Advisor at WuXi AppTec, Lab Testing Division. He has also served on the Board of Directors of Ardent Pharmaceuticals and Enhance Biotech, Inc.

Jinn has been very active in public services including many non-profit scientific associations and charitable organizations. Dr. Wu was the recipient of The Jack L. Beal Postbaccalaureate Award (1994), College of Pharmacy, The Ohio State University and the recipient of the Distinguish Alumni Award (2007) from The National Taiwan University. He is also the Keynote Speaker for the Research Day at the College of Pharmacy, The Ohio State University, April 7, 2015.

What is Jinn Wu's net worth?

The estimated net worth of Jinn Wu is at least $0.00 as of August 22nd, 2022. Dr. Wu owns 484,783 shares of Athenex stock worth more than $0 as of April 25th. This net worth evaluation does not reflect any other assets that Dr. Wu may own. Learn More about Jinn Wu's net worth.

How do I contact Jinn Wu?

The corporate mailing address for Dr. Wu and other Athenex executives is 1001 Main Street Suite 600, Buffalo NY, 14203. Athenex can also be reached via phone at (716) 427-2950 and via email at [email protected]. Learn More on Jinn Wu's contact information.

Has Jinn Wu been buying or selling shares of Athenex?

Jinn Wu has not been actively trading shares of Athenex within the last three months. Most recently, on Monday, August 22nd, Jinn Wu bought 10,000 shares of Athenex stock. The stock was acquired at an average cost of $0.42 per share, with a total value of $4,200.00. Following the completion of the transaction, the director now directly owns 484,783 shares of the company's stock, valued at $203,608.86. Learn More on Jinn Wu's trading history.

Who are Athenex's active insiders?

Athenex's insider roster includes Kim Campbell (Director), Rudolf Kwan (EVP), Johnson Lau (CEO), Jinn Wu (Director), and William Zuo (Insider). Learn More on Athenex's active insiders.

Jinn Wu Insider Trading History at Athenex

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/22/2022Buy10,000$0.42$4,200.00484,783View SEC Filing Icon  
11/17/2021Buy30,000$2.03$60,900.00View SEC Filing Icon  
10/1/2021Buy10,000$2.67$26,700.00View SEC Filing Icon  
9/14/2021Buy50,000$3.22$161,000.00View SEC Filing Icon  
10/15/2018Buy12,500$13.47$168,375.00311,208View SEC Filing Icon  
9/6/2018Buy2,500$16.09$40,225.00266,708View SEC Filing Icon  
8/20/2018Buy5,000$17.20$86,000.004,000View SEC Filing Icon  
3/26/2018Buy10,000$14.66$146,600.00259,208View SEC Filing Icon  
2/9/2018Buy10,000$13.64$136,400.00249,208View SEC Filing Icon  
See Full Table

Jinn Wu Buying and Selling Activity at Athenex

This chart shows Jinn Wu's buying and selling at Athenex by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Athenex Company Overview

Athenex logo
Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapies for the treatment of cancer. It operates through the Oncology Innovation Platform and Commercial Platform segments. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Commercial Platform segment covers the sale and market of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $0.95
Low: $0.20
High: $1.52

2 Week Range

Now: N/A

Volume

1,880,200 shs

Average Volume

194,316 shs

Market Capitalization

$1.76 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.36